IPA’s 10th Advanced GMP Workshop Calls for Unified Quality Vision to Power India’s USD 450 Billion Pharma Ambition

▴ IPA’s 10th Advanced GMP Workshop
Reinforcing its commitment to strengthening global manufacturing and quality benchmarks, the Indian Pharmaceutical Alliance (IPA) convened the 10th Advanced Good Manufacturing Practices (GMP) Workshop. The two-day virtual programme brought together more than 20 industry leaders, domain experts, and international regulators.

Mumbai, November 24, 2025: Reinforcing its commitment to strengthening global manufacturing and quality benchmarks, the Indian Pharmaceutical Alliance (IPA) convened the 10th Advanced Good Manufacturing Practices (GMP) Workshop. The two-day virtual programme brought together more than 20 industry leaders, domain experts, and international regulators.

 

The workshop drew participation from CXOs, academicians, and experts from the US FDA, MHRA (UK), WHO, CDSCO, NCL, and Medicines for Europe. Discussions spanned a diverse array of critical and emerging areas, including Artificial Intelligence and Automation in pharmaceuticals, India’s Biosimilar landscape, Next-Generation Facility and Process Design, Capability Enhancement, Evolving Regulatory Expectations, and Future-ready Manufacturing Practices.

 

The programme commenced with a welcome address by Mr Sudarshan Jain, Secretary General, IPA, followed by opening remarks from Mr Nilesh Gupta, Chair, Quality Forum, IPA & Managing Director, Lupin, and Mr Gregory Smith, Country Director, India Office, Office of Global Operations, USFDA. The keynote address was delivered by Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), CDSCO.

 

Dr Rajeev Raghuvanshi, Drugs Controller General of India, CDSCO, Government of India, said, “IPA’s capacity-building initiatives, training infrastructure, and platforms such as the Advanced GMP are significant enablers, but real progress will emerge only when every stakeholder view quality as non-negotiable. When we work in unison, we will not only meet our national aspirations but also exceed global expectations for innovative, affordable medicines from India.”

 

Mr Nilesh Gupta, Chair, Quality Forum, IPA & Managing Director, Lupin, said, “India today is home to more than 750 USFDA-approved facilities and has achieved a 50 per cent reduction in OAI outcomes over the past three years, clear evidence of what intent, capability, and collaboration can deliver. Our improved alignment with agencies such as the USFDA, EMA, and EDQM reflects the shared commitment of industry and regulators to elevating quality standards.”

 

Mr Sudarshan Jain, Secretary General, IPA, said, “Quality is the fundamental licence to operate in the pharmaceutical sector. This 10th edition gathers global experts to examine pivotal themes such as continuous manufacturing, artificial intelligence, biosimilars, and facility designs. The strong participation reflects the industry’s commitment to advancing India’s quality movement.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026